Georgia Sarquella Brugada
Jefe de Grupo
Research group
Research line:
Pediatric arrhythmias, genetic cardiology and sudden death
Georgia Sarquella-Brugada graduated in Medicine in 2001 from the University of Barcelona and obtained her Doctor of Medicine degree from the University of Barcelona in 2015. She has a master's degree in pediatric cardiology from the University of Barcelona, a pediatric electrophysiology master's degree from the University of Alcalà; and postgraduate degree in Medical Genetics from the University of Valencia and Familial Heart Diseases from the Menéndez Pelayo University.
Between 2007 and 2009 she did a fellowship at the Hôspital Sainte Justine in Montréal, Canada and from 2009 to 2011 at the necker Enfants Malades in Paris.
Since 2012 she has been a professor at the University of Girona and coordinator of the European Network of Rare Cardiac Diseases in Pediatrics.
In 2011 she joined the Cardiology service as an assistant and since 2015 she has been Head of the Arrhythmia Unit at Hospital Sant Joan de Déu.
She currently leads the research group on pediatric arrhythmias, genetic cardiology and sudden death and how to apply this knowledge in personalized therapies in patients with genetic diseases.
Last Publications
- Martínez-Barrios E, Arbelo E, Cesar S, Cruzalegui JC, Fiol JV, Díez-Escuté N, Hernández-Cera C, Brugada R, Brugada-Terradellas J, Campuzano O and Sarquella-Brugada G Brugada Syndrome in Women: What Do We Know After 30 Years? frontiers in cardiovascular medicine . 9: 874992-874992.
- Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Ziólkowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, Vlagkouli V, Weintraub R, King I, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Drago F, Kubuš P, Daubeney PEF, Chivers S, Sarquella-Brugada G, Cesar S, Marrone C, Medrano C, Alvarez Garcia-Roves R, Uzun O, Gran F, Castro FJ, Gimeno JR, Barriales-Villa R, Rueda F, Adwani S, Searle J, Bharucha T, Siles A, Usano A, Rasmussen TB, Jones CB, Kubo T, Mogensen J, Reinhardt Z, Cervi E, Elliott PM, Omar RZ and Kaski JP The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY . 29(4): 645-653.
- Martínez-Barrios E, Sarquella-Brugada G, Pérez-Serra A, Fernández-Falgueras A, Cesar S, Coll M, Puigmulé M, Iglesias A, Alcalde M, Vallverdú-Prats M, Ferrer-Costa C, Del Olmo B, Picó F, López L, Fiol JV, Cruzalegui JC, Hernández-Cera C, Arbelo E, Grassi S, Oliva A, Toro R, Brugada-Terradellas J, Brugada R and Campuzano O Discerning the Ambiguous Role of Missense TTN Variants in Inherited Arrhythmogenic Syndromes. Journal of Personalized Medicine . 12(2): .
Projects
- Project name:
- Identificación de predictores de arritmias cardiacas y muerte súbita en pacientes pediatricos afectos de enfermedades neuromusculares
- Leader
- Georgia Sarquella Brugada
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI21/00094
- Starting - finishing date:
- 2022 - 2024
- Project name:
- Mort sobtada infantil
- Leader
- Georgia Sarquella Brugada
- Funding entities:
- Fundació Bancària " La Caixa"
- Code
- LCF/PR/GN19/50320002
- Starting - finishing date:
- 2020 - 2023
- Project name:
- Analysis of implantable loop recorder data in pediatric patients with non-high-risk Brugada síndrome
- Leader
- Georgia Sarquella Brugada
- Funding entities:
- Medtronic Iberica S.A
- Code
- PCP00276
- Starting - finishing date:
- 2020 - 2021
News
-
Detecting long QT syndrome early could help reduce the impact of sudden infant death
A team led by Dra. Georgia Sarquella (IRSJD) and Drs. Ramon Brugada and Oscar Campuzano (IDIBGI) provide new diagnostic measures to prevent sudden infant death from long QT syndrome.
-
First scientific conference on nanotechnology and rare diseases
The Spanish nanomedicine platform (Nanomed Spain), together with the Sant Joan de Déu Research Institute and the IBEC (Institute of Bioengineering of Catalonia), organised an event within the framework of the Rare Disease Day at which they presented the latest innovations in the field of nanomedicine for the treatment and diagnosis of these diseases.